Renibus Therapeutics Patents – Insights & Stats (Updated 2026)

Renibus Therapeutics has a total of 117 patents globally, out of which 33 have been granted. Of these 117 patents, more than 82% patents are active. United States of America is where Renibus Therapeutics has filed the maximum number of patents, followed by Japan and Hong Kong. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Renibus Therapeutics.

Renibus Therapeutics founded in 2016, Renibus is a clinical-stage biopharmaceutical company developing first-in-class therapies to prevent disease progression and protect against organ damage in cardiorenal conditions. Its lead program, RBT-1, is advancing through late-stage development for reducing postoperative complications, supported by a broader pipeline targeting kidney injury, fibrosis, and inflammatory diseases.

Do read about some of the most popular patents of Renibus Therapeutics which have been covered by us in this article and also you can find Renibus Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Renibus Therapeutics patent portfolio.

How many patents does Renibus Therapeutics have?

Renibus Therapeutics has a total of 117 patents globally. These patents belong to 13 unique patent families. Out of 117 patents, 96 patents are active.

How Many Patents did Renibus Therapeutics File Every Year?

Renibus Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRenibus Therapeutics Applications FiledRenibus Therapeutics Patents Granted
202574
20242010
20231015
2022134
202121
202032
201914

How many Renibus Therapeutics patents are Alive/Dead?

Worldwide Patents

Renibus Therapeutics Patents Portfolio

How Many Patents did Renibus Therapeutics File in Different Countries?

Renibus Therapeutics Worldwide Patents

Countries in which Renibus Therapeutics Filed Patents

CountryPatents
United States of America19
Japan9
Hong Kong (S.A.R.)9
Europe (EPO)7
Singapore6
China6
India5
Australia5
Korea (South)5
Canada5
Mexico4
Israel3
Brazil3
South Africa2
Malta1
Macao1
Albania1
Hungary1
New Zealand1
Croatia1
Slovenia1
Spain1
Poland1
Serbia1
Denmark1
Finland1
Austria1
Germany1
Italy1
Lithuania1
Portugal1
Norway1

Where are Research Centres of Renibus Therapeutics Patents Located?

Renibus Therapeutics Best Patent

US11435364B2 is the most popular patent in the Renibus Therapeutics portfolio. It has received 5 citations so far.

What Percentage of Renibus Therapeutics US Patent Applications were Granted?

Renibus Therapeutics (Excluding its subsidiaries) has filed 16 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 88.89%.

Below are the key stats of Renibus Therapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Renibus Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Culhane Meadows Pllc1688.89%

What are Renibus Therapeutics key innovation segments?

What Technologies are Covered by Renibus Therapeutics?

The chart below distributes patents filed by Renibus Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Renibus Therapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Renibus Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Renibus Therapeutics?

Related Articles

Was this article helpful?

Leave a Comment

Upcoming Global Patent and Innovation Leadership Report - 2026